Second-generation antipsychotic prescribing on the increase

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sertraline: A Review of its Use in the Management of Major Depressive Disorder in Elderly Patients

By Muijsers R.B.R.   Plosker G.L.   Noble S.  

Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. : 377-392

Adis International

Access to resources Recommend Favorite

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

By Nichols Alice I   Tourian Karen A   Tse Susanna Y   Paul Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1565-1574

Informa Healthcare

Access to resources Recommend Favorite

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

By Mancini Michele   Perna Giampaolo   Rossi Andrea   Petralia Antonino  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1167-1181

Informa Healthcare

Access to resources Recommend Favorite

Evidence for the use of vilazodone in the treatment of major depressive disorder

By Reinhold Jennifer A   Mandos Laura A   Lohoff Falk W.   Rickels Karl  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2215-2224

Informa Healthcare

Access to resources Recommend Favorite